| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1617575 | 6480464 | Ethinyl Estradiol affects the expression of CKS1B mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1617575 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CKS1B mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1617575 | 6480464 | Ethinyl Estradiol results in increased expression of CKS1B mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CKS1B mRNA | CTD | PMID:11179685 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CKS1B mRNA | CTD | PMID:11179685 more ... |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CKS1B mRNA | CTD | PMID:16474171 PMID:19167446 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CKS1B mRNA | CTD | PMID:11179685 PMID:23019147 |
| 17beta-estradiol | affects expression | ISO | RGD:1617575 | 6480464 | Estradiol affects the expression of CKS1B mRNA | CTD | PMID:15598610 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | diindolylmethane promotes the reaction [Estradiol results in decreased expression of CKS1B mRNA]; more ... | CTD | PMID:11179685 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CKS1B mRNA | CTD | PMID:16474171 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [Estradiol results in decreased expression of CKS1B mRNA] | CTD | PMID:11179685 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1561797 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CKS1B mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1617575 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CKS1B mRNA | CTD | PMID:17942748 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1617575 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of CKS1B mRNA | CTD | PMID:19191707 |
| acetylsalicylic acid | increases expression | EXP | | 6480464 | Aspirin results in increased expression of CKS1B mRNA | CTD | PMID:14976132 |
| arsenite(3-) | decreases expression | ISO | RGD:1617575 | 6480464 | arsenite results in decreased expression of CKS1B mRNA | CTD | PMID:18929588 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1617575 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of CKS1B mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1617575 | 6480464 | Benzo(a)pyrene results in decreased expression of CKS1B mRNA | CTD | PMID:19770486 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CKS1B mRNA | CTD | PMID:16474171 |
| calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of CKS1B mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CKS1B mRNA | CTD | PMID:21592394 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:1617575 | 6480464 | Ciguatoxins affects the expression of CKS1B mRNA | CTD | PMID:18353800 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CKS1B mRNA | CTD | PMID:19376846 |
| copper atom | multiple interactions | ISO | RGD:1617575 | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CKS1B mRNA | CTD | PMID:15467011 |
| copper atom | increases expression | ISO | RGD:1617575 | 6480464 | Copper results in increased expression of CKS1B mRNA | CTD | PMID:17205981 |
| copper(0) | multiple interactions | ISO | RGD:1617575 | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CKS1B mRNA | CTD | PMID:15467011 |
| copper(0) | increases expression | ISO | RGD:1617575 | 6480464 | Copper results in increased expression of CKS1B mRNA | CTD | PMID:17205981 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of CKS1B mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS1B mRNA; more ... | CTD | PMID:19167446 |
| coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of CKS1B mRNA | CTD | PMID:19167446 |
| cumene | multiple interactions | ISO | RGD:1617575 | 6480464 | [cumene co-treated with KRAS gene mutant form] results in decreased expression of CKS1B mRNA | CTD | PMID:18648096 |
| cyclosporin A | increases expression | ISO | RGD:1617575 | 6480464 | Cyclosporine results in increased expression of CKS1B mRNA | CTD | PMID:19770486 |
| dasatinib (anhydrous) | decreases expression | EXP | | 6480464 | dasatinib results in decreased expression of CKS1B mRNA | CTD | PMID:20579391 |
| dibutyl phthalate | decreases expression | ISO | RGD:1617575 | 6480464 | Dibutyl Phthalate results in decreased expression of CKS1B mRNA | CTD | PMID:17361019 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of CKS1B mRNA | CTD | PMID:15766595 |
| disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of CKS1B mRNA | CTD | PMID:18175754 |
| fluoxetine | multiple interactions | EXP | | 6480464 | [Fluoxetine results in decreased activity of CKS1B protein] which results in decreased degradation of CCNE1 protein; more ... | CTD | PMID:18371935 |
| fluoxetine | decreases expression | EXP | | 6480464 | Fluoxetine results in decreased expression of CKS1B mRNA | CTD | PMID:18371935 |
| genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of CKS1B mRNA | CTD | PMID:16474171 |
| lucanthone | decreases expression | EXP | | 6480464 | Lucanthone results in decreased expression of CKS1B mRNA | CTD | PMID:21148553 |
| menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of CKS1B mRNA | CTD | PMID:20044591 |
| naphthalene | increases expression | ISO | RGD:1617575 | 6480464 | naphthalene results in increased expression of CKS1B mRNA | CTD | PMID:18978301 |
| ochratoxin A | increases expression | ISO | RGD:1561797 | 6480464 | ochratoxin A results in increased expression of CKS1B mRNA | CTD | PMID:23358140 |
| ozone | multiple interactions | ISO | RGD:1617575 | 6480464 | TTPA protein affects the reaction [Ozone results in increased expression of CKS1B mRNA] | CTD | PMID:19555225 |
| ozone | increases expression | ISO | RGD:1617575 | 6480464 | Ozone results in increased expression of CKS1B mRNA | CTD | PMID:12763052 |
| paracetamol | affects expression | ISO | RGD:1617575 | 6480464 | Acetaminophen affects the expression of CKS1B mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CKS1B mRNA | CTD | PMID:22230336 |
| parathion | decreases expression | EXP | | 6480464 | Parathion results in decreased expression of CKS1B mRNA | CTD | PMID:17622325 |
| phenobarbital | affects expression | ISO | RGD:1617575 | 6480464 | Phenobarbital affects the expression of CKS1B mRNA | CTD | PMID:23091169 |
| pirinixic acid | decreases expression | ISO | RGD:1617575 | 6480464 | pirinixic acid results in decreased expression of CKS1B mRNA | CTD | PMID:18445702 |
| propiconazole | increases expression | ISO | RGD:1617575 | 6480464 | propiconazole results in increased expression of CKS1B mRNA | CTD | PMID:21278054 |
| resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CKS1B mRNA | CTD | PMID:19167446 |
| sirolimus | decreases expression | ISO | RGD:1617575 | 6480464 | Sirolimus results in decreased expression of CKS1B mRNA | CTD | PMID:11355896 |
| tamoxifen | affects expression | ISO | RGD:1617575 | 6480464 | Tamoxifen affects the expression of CKS1B mRNA | CTD | PMID:17555576 |
| testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CKS1B mRNA | CTD | PMID:21592394 |
| testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of CKS1B mRNA | CTD | PMID:21592394 |
| tetrachloromethane | increases expression | ISO | RGD:1617575 | 6480464 | Carbon Tetrachloride results in increased expression of CKS1B mRNA | CTD | PMID:17484886 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CKS1B mRNA | CTD | PMID:19167446 |
| trimellitic anhydride | increases expression | ISO | RGD:1617575 | 6480464 | trimellitic anhydride results in increased expression of CKS1B mRNA | CTD | PMID:19042947 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CKS1B mRNA | CTD | PMID:19140230 |
| urethane | increases expression | ISO | RGD:1617575 | 6480464 | Urethane results in increased expression of CKS1B mRNA | CTD | PMID:16289808 |
| vancomycin | decreases expression | ISO | RGD:1617575 | 6480464 | Vancomycin results in decreased expression of CKS1B mRNA | CTD | PMID:18930951 |